Company Report
Last edited 7 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#35
Performance (41m)
-16.4% pa
Followed by
20
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Risks
stale
Added 7 months ago

Note: Don’t hold sold out a few months back. I am interested in getting back in.

Are the risks that Phase 3 results are not as good as people are expecting? Digging into the Phase 2 results showed (see below).

I don’t know it’s not exactly what I would say shooting the lights out. Just trying to get a sense if it’s worth getting back in.

I just had a feeling the report (Phase 2 trial shows significant improvements in Pitt Hopkins) released 27/5 wasn’t as up beat as previous.


4de588104981b917a88d74df0a6198c4851527.png


be1730fe8b58358bc4d74ee2d01b0b6988e6bc.png